Leukemic spleen cells are more potent than bone marrow-derived cells in a transgenic mouse model of CML-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Leukemic spleen cells are more potent than bone marrow-derived cells in a transgenic mouse model of CML

Published:2011-12-23 Issue:5 Volume:26 Page:1030-1037
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Schemionek M,Spieker T,Kerstiens L,Elling C,Essers M,Trumpp A,Berdel W E,Müller-Tidow C,Koschmieder S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2011366.pdf

Reference32 articles.

1. Fialkow PJ, Jacobson RJ, Papayannopoulou T . Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977; 63: 125–130.

2. Takahashi N, Miura I, Saitoh K, Miura AB . Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Blood 1998; 92: 4758–4763.

3. Druker BJ, Guilhot F, O′Brien SG, Gathmann I, Kantarjian H, Gattermann N et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408–2417.

4. Kantarjian H, Giles F, Wunderle L, Bhalla K, O′Brien S, Wassmann B et al. Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL. N Engl J Med 2006; 354: 2542–2551.

5. Talpaz M, Shah NP, Kantarjian H, Donato N, Nicoll J, Paquette R et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med 2006; 354: 2531–2541.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asciminib antagonizes transplantable BCR::ABL1-positive lymphoid blast crisis in vivo by targeting malignant stem cells;Leukemia;2024-06-21

2. Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib;Blood Cancer Journal;2023-09-11

3. Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients;Frontiers in Pharmacology;2023-07-04

4. The cytokine network in acute myeloid leukemia;Frontiers in Immunology;2022-09-28

5. Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistance;Leukemia;2022-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3